A number of other firms have also recently commented on SUMR. Analysts at Roth Capital reiterated a “buy” rating on shares of Summer Infant in a research note to investors on Tuesday. Separately, analysts at Wedbush cut their price target on shares of Summer Infant from $6.00 to $5.00 in a research note to investors on Tuesday. Finally, analysts at Needham & Company reiterated a “strong-buy” rating on shares of Summer Infant in a research note to investors on Monday.
Summer Infant traded down 6.25% on Tuesday, hitting $3.00. Summer Infant has a 52-week low of $3.16 and a 52-week high of $9.04. The company has a market cap of $53.9 million and a price-to-earnings ratio of 15.17.
Summer Infant last posted its quarterly earnings results on Monday, May 14th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by $0.05. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. Analysts expect that Summer Infant will post $0.16 EPS next quarter.
Summer Infant, Inc. is a designer, marketer, and distributor of juvenile health, safety and wellness products, which are sold to North American and the United Kingdom retailers.